THE DEFINITION AND ROLE OF QUALITY OF LIFE IN GERMANY'S EARLY ASSESSMENT OF DRUG BENEFIT

RESULTS
METHODS
CONCLUSIONS
QoL plays an important role in Germany's new system of drug benefit assessment. QoL data are not only appraised as a relevant endpoint per se, but are also consulted in order to put outcomes regarding mortality, morbidity and side effects into context. Due to a rather fast legislation and implementation of early benefit assessment in Germany and the fact that QoL is not easily or universally defined, key players had difficulty agreeing on shared QoL understandings.
QUALITATIVE CONTENT ANALYSIS
To trace the definition and role of QoL in early benefit assessment, all assessments completed by 2013 (n=66) were qualitatively analyzed regarding QoL content. The summaries of the dossiers, dossier evaluations, verbatim protocols of the oral hearings and the G-BA's decisions were processed. Documents were searched for the term QoL and synonyms. We analyzed passages referring to the definition and role of QoL and reduced the original text sources to key content. Identifying recurring themes of references, a system of codes was created categorizing findings on the definition and role of QoL within early drug benefit assessment. The qualitative content analysis was conducted by two researchers independently reviewing and discussing the results at the different stages indicated below: 
